Stockscreener 앱 받기
1.80
7.14%
0.12
전일 마감가:
$1.68
열려 있는:
$1.655
하루 거래량:
109.43K
Relative Volume:
0.27
시가총액:
$66.42M
수익:
-
순이익/손실:
-
주가수익비율:
-0.7144
EPS:
-2.5197
순현금흐름:
-
1주 성능:
+12.50%
1개월 성능:
+9.76%
6개월 성능:
+19.21%
1년 성능:
-11.48%
1일 변동 폭
$1.655
$1.85
1주일 범위
$1.48
$1.85
52주 변동 폭
$0.8786
$2.75
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
1.80 | 61.99M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-09-04 | 개시 | H.C. Wainwright | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Health Catalyst (HCAT) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Significant Increase in Short Interest - Defense World
TerraVest Industries (TSE:TVK) Price Target Raised to C$209.00 at Canaccord Genuity Group - Defense World
Scotiabank Issues Positive Forecast for Quebecor (TSE:QBR.B) Stock Price - Defense World
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 6,821.4% in December - MarketBeat
Adlai Nortye narrows first-half 2025 loss as oncology pipeline advances - MSN
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Sahm
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Xoma (XOMA) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Sahm
Adlai Nortye Ltd ADR (ANL-Q) Stock Price and News - The Globe and Mail
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm - Investing.com India
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China - TipRanks
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal - Investing.com
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - Sahm
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% HigherWhat's Next? - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% Higher – What’s Next? - Defense World
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Regeneron (REGN) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR Cash Flow – LS:A3EEED - TradingView — Track All Markets
Total common shares outstanding of Adlai Nortye Ltd. Sponsored ADR – LS:A3EEED - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Terns Pharmaceuticals (TERN) and Pyxis Oncology (PYXS) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4% – Here’s Why - Defense World
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4%Here's Why - MarketBeat
Adlai Nortye to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Vera Therapeutics (VERA) and Varex Imaging (VREX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail
H.C. Wainwright Reaffirms Their Hold Rating on Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Adlai Nortye Ltd. Plans Redomiciliation to Singapore - MSN
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 92.3% in September - MarketBeat
HC Wainwright Comments on Adlai Nortye FY2025 Earnings - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading Down 3.1%Here's Why - MarketBeat
GASFRAC Energy Services (OTCMKTS:GSFVF) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Chart based analysis of Adlai Nortye Ltd. Depositary Receipt trendsQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can technical indicators confirm LZ Technology Holdings Limited’s reversalMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
How to monitor COHU with trend dashboards2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Can machine learning forecast Ubiquiti Inc. recoveryQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Top chart patterns to watch in ECARX Holdings Inc. Equity WarrantWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), AnaptysBio (ANAB) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Visual analytics tools that track Adlai Nortye Ltd. Depositary Receipt performanceMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does PBHC show high probability of reboundJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Penns Woods Bancorp Inc.2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is MSBI trending in predictive chart modelsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Declines By 65.7% - MarketBeat
Does Bentley Systems Incorporated qualify in momentum factor screening2025 Key Highlights & Consistent Return Investment Signals - newser.com
Earnings visualization tools for WSO.BJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Earnings visualization tools for DBRG.PRJQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Adlai Nortye Ltd Adr (ANL) 재무 분석
Adlai Nortye Ltd Adr (ANL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):